These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3664425)

  • 21. Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery.
    Noguchi H; Yamashita H; Murakami T; Hirai K; Noguchi Y; Maruta J; Yokoi T; Noguchi S
    Endocr J; 2009; 56(2):245-9. PubMed ID: 19088401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
    Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
    Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
    Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
    Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The combined treatment of anaplastic thyroid carcinoma].
    Serrano M; Monroy C; Rodríguez-García JL; País JR; Fernández-Garrido M
    An Med Interna; 1994 Jun; 11(6):288-90. PubMed ID: 7918941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation and low dose adriamycin for the treatment of carcinoma of the hypopharynx.
    Yamazaki H; Inoue T; Tanaka E; Yoshida K; Imai A; Yoshioka Y; Nakamura H; Yoshida J; Inoue T
    Anticancer Res; 2000; 20(6C):4713-20. PubMed ID: 11205206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaplastic carcinoma of the thyroid gland treated by radiation therapy.
    Levendag PC; De Porre PM; van Putten WL
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):125-8. PubMed ID: 8482618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma in childhood.
    Kim TH; McLaren J; Alvarado CS; Wyly JB; Crocker I; Winn K; Singhapakdi S; Ragab A
    Cancer; 1989 May; 63(10):1922-6. PubMed ID: 2649220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
    Perez CA; Pajak TF; Rubin P; Simpson JR; Mohiuddin M; Brady LW; Perez-Tamayo R; Rotman M
    Cancer; 1987 Jun; 59(11):1874-81. PubMed ID: 3032394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel.
    Troch M; Koperek O; Scheuba C; Dieckmann K; Hoffmann M; Niederle B; Raderer M
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E54-7. PubMed ID: 20591979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaplastic giant cell thyroid carcinoma.
    Wallin G; Lundell G; Tennvall J
    Scand J Surg; 2004; 93(4):272-7. PubMed ID: 15658667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoma showing thymus-like element (CASTLE) of thyroid: combined modality treatment in 3 patients with locally advanced disease.
    Chow SM; Chan JK; Tse LL; Tang DL; Ho CM; Law SC
    Eur J Surg Oncol; 2007 Feb; 33(1):83-5. PubMed ID: 17085008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.